Dystrophin peptide compounds are synthetic oligopeptides derived from the dystrophin protein, which plays a vital role in connecting the cytoskeleton of a muscle fiber to the extracellular matrix. Mutations… Read more
Dystrophin peptide compounds are synthetic oligopeptides derived from the dystrophin protein, which plays a vital role in connecting the cytoskeleton of a muscle fiber to the extracellular matrix. Mutations in the gene encoding this protein are the primary cause of Duchenne muscular dystrophy and Becker muscular dystrophy, conditions characterized by muscle degeneration. In pharmaceutical and clinical research, these peptides function as critical reference standards for the quantification of endogenous dystrophin levels, typically via liquid chromatography-tandem mass spectrometry (LC-MS/MS) assays. Laboratories utilize stable isotope labelled versions of these peptides as internal standards to improve the accuracy of analytical method validation and to ensure precise impurity profiling during quality control processes. By providing reliable benchmarks, these synthetic standards support the development and clinical assessment of novel therapeutic interventions aimed at restoring dystrophin expression in affected tissues.